Oramed Pharmaceuticals
ORMP
ORMP
28 hedge funds and large institutions have $5.7M invested in Oramed Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
33% less capital invested
Capital invested by funds: $8.45M → $5.7M (-$2.75M)
Holders
28
Holding in Top 10
1
Calls
$111K
Puts
$3K
Top Buyers
| 1 | +$395K | |
| 2 | +$231K | |
| 3 | +$120K | |
| 4 |
Renaissance Technologies
New York
|
+$53.2K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$48K |
Top Sellers
| 1 | -$459K | |
| 2 | -$243K | |
| 3 | -$114K | |
| 4 |
Squarepoint
New York
|
-$71K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$4.56K |